APPLICATION OF ORGANIC COMPOUNDS Russian patent published in 2011 - IPC A61K31/165 A61P9/00 A61P5/50 A61P13/12

Abstract RU 2426532 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed group of inventions relates to medicine, namely to therapy and deals with application of organic compound -rennin inhibitor aliskiren for treatment and prevention of type 2 diabetes and kidney disease. For this purpose aliskiren is introduced in efficient amount as monotherapy.

EFFECT: invention ensures efficient treatment and prevention of said diseases due to aliskiren ability to increase sensitivity of tissues to insulin and reduce proteinuria.

5 cl

Similar patents RU2426532C2

Title	Year	Author	Number
RENIN INHIBITOR-CONTAINING SYNERGETIC COMPOSITIONS DESIGNATED FOR TREATMENT OF CARDIOVASCULAR DISEASE	2001	Kheuitt Uill'Jam Vasella Dan'El' Lusi Uehbb Randi Li	RU2310443C2
SYNERGETIC COMBINATIONS CONTAINING RENIN INHIBITOR AND INTENDED FOR TREATMENT OF CARDIOVASCULAR DISEASES	2006	Kheuitt Uill'Jam Vasella Dae'El' Lusi Uehbb Randi Li	RU2346703C2
PHARMACEUTICAL COMPOSITION INCLUDING RENIN INHIBITOR, CALCIUM CHANNEL BLOCKER AND DIURETIC	2003	Feldman Dejvid Luis Uehbb Randi Li	RU2316318C2
COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE	2003	Olme David Grenvill' Shetti Suraj Shivappa Kh'Juz Tomas Ehduard	RU2336876C2
SALT OF ALISKIREN AND SULFURIC ACID	2007	All'Mendinger Tomas Shtovasser Frank	RU2439054C2
(-AMINO-(-HYDROXY-(-ARYLALKANOIC AMIDES AND USE THEREOF AS RENIN INHIBITORS	2004	Zell'Ner Khol'Ger Gross Gerkhard Majbaum Jurgen Klaus Kotten Sil'Ven	RU2425027C2
RAPAMYCIN DERIVATIVE OR IMPDH INHIBITOR FOR TREATING POLYCYSTIC KIDNEY DISEASE	2006	Fehrber Lotar Gshajdmajer Kharal'D	RU2491933C2
ALISKIREN AND OROTIC ACID SALT	2007	Rebe Zhan-Lui Shtovasser Frank	RU2456267C2
ADMINISTRATION OF RENIN INHIBITORS FOR PREVENTION OR TREATMENT OF DIASTOLIC DYSFUNCTION OR DIASTOLIC HEART FAILURE	2005	Feldman Dejvid Luis Luft Fridrikh Kameron Mjuller Dominik Nikolas Uehbb Randi Li	RU2407523C2
COMBINATION OF AT LEAST TWO COMPOUNDS CHOSEN FROM GROUPS AT-RECEPTOR ANTAGONISTS OR INHIBITORS OF ACE (ANGIOTENSIN-CONVERTING ENZYME) OR INHIBITORS OF HMG-COA-REDUCTASE (BETA-HYDROXY-BETA-METHYLGLUTARYL-COENZYME-A-REDUCTASE)	2001	De-Gasparo Mark Grejvz Kurt S.	RU2298418C2

RU 2 426 532 C2

Authors

Feldman Dejvid Luis

Zelenkofske Stiven

Dinbbek Mikhaehla

Preskott Margaret Forni

Dates

2011-08-20—Published

2005-03-16—Filed